当前位置:首页 - 行情中心 - 国药现代(600420) - 财务分析 - 现金流量表

国药现代

(600420)

  

流通市值:144.04亿  总市值:144.04亿
流通股本:13.41亿   总股本:13.41亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金10,431,219,711.338,063,674,065.435,541,758,391.532,927,957,863.3
收到的税费返还79,644,554.1731,042,213.9219,953,600.9510,883,051.91
收到其他与经营活动有关的现金312,641,925.81414,634,771.67890,163,266.77201,072,402.94
经营活动现金流入的平衡项目0000
经营活动现金流入小计10,823,506,191.318,509,351,051.026,451,875,259.253,139,913,318.15
购买商品、接受劳务支付的现金4,367,396,431.083,392,793,453.042,318,605,934.781,172,877,325.06
支付给职工以及为职工支付的现金1,783,370,277.251,299,639,115.27887,424,939.91510,641,763.5
支付的各项税费772,688,716.73591,153,950.53455,512,208.09239,882,899.73
支付其他与经营活动有关的现金1,644,070,070.471,199,304,587.55973,324,777.25505,106,422.31
经营活动现金流出的平衡项目0000
经营活动现金流出小计8,567,525,495.536,482,891,106.394,634,867,860.032,428,508,410.6
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,255,980,695.782,026,459,944.631,817,007,399.22711,404,907.55
二、投资活动产生的现金流量:
收回投资收到的现金3,003,077.142,286,637.19--
取得投资收益收到的现金17,098,554.236,881,470.82--
处置固定资产、无形资产和其他长期资产收回的现金净额21,945,397.9414,728,000.481,196,950.28811,982.28
收到的其他与投资活动有关的现金1,611,499,500677,573,861.16--
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,653,546,529.31701,469,969.651,196,950.28811,982.28
购建固定资产、无形资产和其他长期资产支付的现金219,772,901.59156,028,789.97110,215,678.2856,070,994.8
支付其他与投资活动有关的现金2,290,000,0001,900,000,000497,000,000130,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,509,772,901.592,056,028,789.97607,215,678.28186,070,994.8
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-856,226,372.28-1,354,558,820.32-606,018,728-185,259,012.52
三、筹资活动产生的现金流量:
取得借款收到的现金50,000,00050,000,00020,000,000-
筹资活动现金流入平衡项目000-
筹资活动现金流入小计50,000,00050,000,00020,000,000-
偿还债务支付的现金45,000,00045,000,00025,000,000-
分配股利、利润或偿付利息支付的现金380,948,691.46379,369,643.21172,797,716.6936,101,474.56
其中:子公司支付给少数股东的股利、利润80,266,646.4481,037,635.296,951,628.164,500,000
支付其他与筹资活动有关的现金39,467,791.0732,695,096.0711,920,872.98,911,256.82
筹资活动现金流出平衡项目0000
筹资活动现金流出小计465,416,482.53457,064,739.28209,718,589.5945,012,731.38
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-415,416,482.53-407,064,739.28-189,718,589.59-45,012,731.38
四、汇率变动对现金及现金等价物的影响29,631,385.7424,552,595.3418,510,922.582,498,251.03
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,013,969,226.71289,388,980.371,039,781,004.21483,631,414.68
加:期初现金及现金等价物余额5,131,044,857.85,131,044,857.85,131,044,857.85,134,331,493.77
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额6,145,014,084.515,420,433,838.176,170,825,862.015,617,962,908.45
补充资料:
净利润1,332,079,710.25-886,887,725.63-
资产减值准备168,498,777.81-11,308,517.94-
固定资产和投资性房地产折旧727,988,570.37-360,850,118.54-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧727,988,570.37-360,850,118.54-
无形资产摊销44,329,510.35-20,531,958.47-
长期待摊费用摊销5,984,305.93-3,708,034-
处置固定资产、无形资产和其他长期资产的损失31,310,025.43-2,049,581.83-
固定资产报废损失1,879,784.01-566,673.5-
财务费用36,887,575.36-18,697,936.94-
投资损失-64,105,907.49--16,838,682.09-
递延所得税98,613,199.23-61,925,459.78-
其中:递延所得税资产减少49,988,418.44-7,073,396.21-
递延所得税负债增加48,624,780.79-54,852,063.57-
存货的减少60,541,406.93--5,360,046.11-
经营性应收项目的减少732,852,196.59-240,245,336.14-
经营性应付项目的增加-918,522,479.01-221,636,177.3-
现金的期末余额6,145,014,084.51-6,170,825,862.01-
减:现金的期初余额5,131,044,857.8-5,131,044,857.8-
公告日期2025-03-282024-10-292024-08-282024-04-30
审计意见(境内)标准无保留意见
TOP↑